Transcript Chem 125 Lecture 10 9/26/07 Preliminary

Chemistry 125: Lecture 27
November 6, 2009
Communicating Molecular Structure
in Diagrams and Words
It is important that chemists agree on notation and nomenclature in order to communicate
molecular constitution and configuration. Clear notation also aids clarity of thought. The
conventional 1891 Fischer projection, which has been indispensable in understanding sugar
configurations for over a century, was invented in order to count stereoisomers. Ambiguity in
diagrams or words has led to multibillion dollar patent disputes involving popular
pharmaceuticals. International agreements provide descriptive, unambiguous, unique,
systematic “IUPAC” names that are reasonably convenient for most organic molecules of
modest molecular weight. Also in 1891 Fischer devised the D,L “genealogical” scheme to
describe relative configurations, but it can be cumbersome or ambiguous.
For copyright
notice see final
page of this file
Configurational Isomer Counting
? n
n "Stereogenic Centers"  2 isomers
No, because of meso compounds
"Next we consider a symmetrical formula:
C(R1 R2 R3)C(R4 R4)C(R1 R2 R3) , and
C(R1 R2 R3)C(R4 R5)C(R1 R2 R3) as well.
As is easily conceived from the forgoing
discussion, they lead to only three isomers."
(Baeyer & Fischer gave up on using bread rolls.) van't Hoff (1877)
Trihydroxyglutaric Acids
23 = 8
HOOC-CH(OH)-CH(OH)-CH(OH)-COOH
1
2
3
(2)
COOH
Meso?
COOH
H
COOH
H
H
OH
HO
H
OH
H
OH
HO
H
OH
H
OH
H
COOH
?
COOH
H
HO
H
OH
H
OH
COOH
COOH
COOH
OH
HO
H
HO
H
HO
H
HO
H
HO
H
H
OH
H
H
OH
H
OH
H
COOH
H
COOH
HO
H
HO
HO
COOH
OH
H
OH
COOH
H
HO
COOH
COOH
COOH
COOH
4
(3)
4
(4)
(1)
2 meso isomers and a pair of enantiomers / easy with Fischer projections
Halichondrin B: A Marine Natural Product with
Potent In Vitro and In Vivo Antitumor Activity
Discovery of E7389 Starting From the
Halichondrin B C.1-C.38 Macrolide
HO
O
HO
H
H
Active Fragment
of Halichondrin B
Structure-Activity
Relationship Study
Me
O
O
O
H
O
O
H
O
19 “stereogenic centers”
OMe
OH
H2N
O
O
H
SAR
O
O
O
halichondrin B C.1-C.38 macrolide
H"Simplified"
Version
of Active Fragment
is Drug Candidate
E7389
H
O O
O O
Me
H
O
O
H
Me
O
H
O
E7389
"In Vitro and In Vivo Anticancer Activities of Synthetic Macrocyclic Ketone Analogues of Halichondrin B"
M.J. Towle, K.A. Salvato, J. Budrow, B.F. Wels, G. Kuznetsov, K.K. Aalfs, S. Welsh, W. Zheng, B.M.
Seletsky, M.H. Palme, G.J. Habgood, L.A. Singer, L.V. DiPietro, Y.Wang, J.J. Chen, D.A. Quincy, A.Davis
K. Yoshimatsu, Y. Kishi, M.J. Yu, and B.A. Littlefield, Cancer Res., February 1, 2001; 61(3): 1013-1021
219 > 500,000 configurational isomers!
ClinicalTrials.gov currently has 80,975 trials
with locations in 170 countries. (Nov. 3, 2009)
E7389 Phase III Nov 2008
(Nov. 7,
3, 2008)
2009)
Lipitor
A $10,000,000,000 Problem
in Stereochemical Notation
The world’s best selling drug ($10.86 billion in 2004)
Oct. 12, 2005
NEW YORK - Pfizer Inc. won a significant victory on
Wednesday when a British judge upheld a key patent covering
its blockbuster cholesterol drug Lipitor in the United Kingdom
but the medication still faces a similar yet more important case
in the United States. (Analogus decision 8/2/2006 in U.S. Court of Appeals)
Judge Nicholas Pumfrey upheld the patent covering
atorvastatin, Lipitor’s active ingredient, but ruled that another
patent was invalid. Indian pharmaceutical company Ranbaxy
Laboratories Ltd. had challenged both patents, and was joined
by Britain’s Arrow Generics Ltd. against the second patent that
was ruled invalid.
Pfizer said the decision upholding the exclusivity of the
patent covering atorvastatin until November 2011 was an
important victory for scientists.
What is Patented?
single enantiomer (Lipitor, drawn in figure)
…
or racemate (described
in text)
F
OH -O
Ca+2
O
H-N
i-Pr
Number of permutations
much greater than the
total number of protons,
neutrons, and electrons
in the Solar system!
Opinion of Sir Nicholas Pumfrey
In the '633 patent, it is absolutely clear from context
throughout that formula (I) is being used to denote a racemate.
In my judgment, every time the skilled person sees formula I or
formula X he will see it with eyes that tell him that in that
racemate, there is a single enantiomer that is the effective
compound, and that he can resolve the racemate using
conventional techniques to extract that enantiomer.
When one comes to claim 1, which echoes the purpose of the
invention with its conventional reference to pharmaceutically
Pfizer’s
latertopatent
acceptable salts, he will, in myThus
judgment,
continue
see the
formulae in this light.
on the single enantiomer
In my view, the claim
is an invalid repeat, and
covers the racemate and
patent protection will run
the individual enantiomers.
out three years earlier !
I
X
Constitutional Nomenclature Conventions
Geneva (1892)
IUPAC, International Union
of Pure & Applied Chemistry
http://www.chem.qmw.ac.uk/iupac/
http://acdlabs.com/iupac/nomenclature
Formal name should be:
• Clearly Descriptive
• Unambiguous
•
Composition, Constitution,
Configuration, Conformation
i.e. Stereochemistry
Unfortunately "Amide" means
One name  one structure
both R2N and RCONH2
Unique Indexing Alternatives: composition, computer graphics
One structure  one name
• Manageable
(e.g. Quick, Easy, Short, Pronounceable)
Systematic Constitutional Nomenclature
bromo
Choose the “Main Chain”methyl
for Greek Root Name
• Longest
• Most Substituents
(to give simpler names)
Number the Chain Atoms
methyl
Br
6
7
3
2 1
5
4
chloro
Cl
2
1
7-bromo-2-chloro-3-ethyl-6,7-dimethylnonane
?
Br
• Lowest number at
First Difference
Name Substituents
3
ethyl
Cl
(1-chloroethyl)
octane
Br
Alphabetize (& Count)
Cl
http://acdlabs.com/iupac/nomenclature/93/r93_338.htm
WOW!
Thank God for pictures and computer graphics.
Some Useful Non-Systematic Names
Isopentane
Isobutane
X
X
Neopentane
X
X
Isopropyl
sec-Butyl
tert-Butyl
Neopentyl
Nomenclature Drill
available on course website.
Configurational Nomenclature
m.p.
[a]D
140°C
0° (meso)
170°C
+13° (dextro +)
170°C
-13° (laevo -)
Phenomenological
Tartaric
Acid Isomers
D/L designation
is
COOH
COOH
COOH
ambiguous without
H
OH
HO
H
H
OH
HO
H
H
OH
having a detailed
?
H
OH
H
OH
HO
H
H
OH
HO
H
synthesis
recipe
Why
or a convention.
COOH
COOH
COOH not?
D-Tartaric Acid
CHO
Genealogical (Fischer, 1891)
Relative (by synthesis) to
H
?
OH
HOCH2CH(OH)CHO
CH2OH
d-(+)-glyceraldehyde
Defined as “D”-glyceraldehyde (Fischer’s Guess)
Multi-Step
Synthesis
First of 210 Tables
Glyceraldehyde
D
D
Lactic Acid
(1978)
Paul D. Bartlett
age 24
Problem for Monday:
Consider HOMO/LUMO
alternatives during the
reaction of HI with
1,3-butanediol to give
4-iodo-2-butanol
>2000 Compounds
in the 210 Tables
24 years old
End of Lecture 27
Nov. 6, 2009
Copyright © J. M. McBride 2009. Some rights reserved. Except for cited third-party materials, and those used by visiting
speakers, all content is licensed under a Creative Commons License (Attribution-NonCommercial-ShareAlike 3.0).
Use of this content constitutes your acceptance of the noted license and the terms and conditions of use.
Materials from Wikimedia Commons are denoted by the symbol
.
Third party materials may be subject to additional intellectual property notices, information, or restrictions.
The following attribution may be used when reusing material that is not identified as third-party content:
J. M. McBride, Chem 125. License: Creative Commons BY-NC-SA 3.0